第十一批集采3个抗肿瘤药火了!700亿市场波澜四起,超12亿品种迎冲击,石药、科伦备战

米内网
Aug 05

精彩内容近期,第十一批集采正式启动,3个抗肿瘤化药拟纳入,超12亿大品种在列。米内网数据显示,2025Q1中国公立医疗机构终端抗肿瘤化药销售额同比增幅3.36%,阿斯利康、正大制药、恒瑞医药强势领跑。品牌TOP20中,4个超5亿独家单品(含剂型独家,下同)高居前列,国产1类新药成爆款。3个拟集采的抗肿瘤化药,石药集团均已过评,科伦药业、齐鲁制药等各有2个品种过评。抗肿瘤化药市场重回700亿!...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10